tiprankstipranks
Faron Pharmaceuticals Oy (DE:4FR)
FRANKFURT:4FR
Germany Market

Faron Pharmaceuticals Oy (4FR) Technical Analysis

8 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Faron Pharmaceuticals Oy’s (4FR) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Faron Pharmaceuticals Oy is a Sell.
Faron Pharmaceuticals Oy’s (4FR) 20-Day exponential moving average is 0.48, while Faron Pharmaceuticals Oy’s (4FR) share price is €0.47, making it a Sell.
Faron Pharmaceuticals Oy’s (4FR) 50-Day exponential moving average is 0.50, while Faron Pharmaceuticals Oy’s (4FR) share price is €0.47, making it a Sell.

Faron Pharmaceuticals Oy (4FR) Pivot Points

Jul 25, 2026, 08:07 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.48
0.48
0.48
0.48
0.48
0.48
0.48
Fibonacci
0.48
0.48
0.48
0.48
0.48
0.48
0.48
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Faron Pharmaceuticals Oy (4FR) Moving Averages

Jul 25, 2026, 08:07 PM
Period
Simple
Exponential
MA5
0.48Buy
0.48Sell
MA10
0.48Sell
0.48Sell
MA20
0.48Sell
0.48Sell
MA50
0.49Sell
0.50Sell
MA100
0.49Sell
0.64Sell
MA200
1.12Sell
1.12Sell
Faron Pharmaceuticals Oy’s (4FR) 10-Day exponential moving average is 0.48, while Faron Pharmaceuticals Oy’s (4FR) share price is €0.47, making it a Sell.
Faron Pharmaceuticals Oy’s (4FR) 100-Day exponential moving average is 0.64, while Faron Pharmaceuticals Oy’s (4FR) share price is €0.47, making it a Sell.
Faron Pharmaceuticals Oy’s (4FR) stock price is €0.47 and Faron Pharmaceuticals Oy’s (4FR) 50-day simple moving average is 0.49, creating a Sell signal.
Faron Pharmaceuticals Oy’s (4FR) stock price is €0.47 and Faron Pharmaceuticals Oy’s (4FR) 100-day simple moving average is 0.49, creating a Sell signal.
Faron Pharmaceuticals Oy’s (4FR) stock price is €0.47 and Faron Pharmaceuticals Oy’s (4FR) 200-day simple moving average is 1.12, creating a Sell signal.

Faron Pharmaceuticals Oy (4FR) Technical Indicators

Jul 25, 2026, 08:07 PM
Name
Value
Implied Action
RSI (14)
47.82
Neutral
STOCH (9,6)
45.24
Neutral
STOCHRSI (14)
27.42
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
10.60
Buy
Williams %R
-60.00
Buy
CCI (14)
-18.87
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
49.41
Neutral
ROC
-5.35
Sell
Faron Pharmaceuticals Oy’s (4FR) Relative Strength Index (RSI) is 47.82, creating a Neutral signal.
Faron Pharmaceuticals Oy’s (4FR) Trend Strength Indicator (ADX) is 10.60, creating a Buy signal.
Faron Pharmaceuticals Oy’s (4FR) Commodity Channel Index (CCI) is -18.87, creating a Neutral signal.
Faron Pharmaceuticals Oy’s (4FR) Price Rate of Change (ROC) is -5.35, creating a Sell signal.

FAQ

Is 4FR a Buy, Hold, or Sell?
Based on 4FR’s technical indicators, 4FR is a Strong Sell.
    What is 4FR’s RSI (14)?
    4FR’s RSI (14) is 47.82, which suggests 4FR is a Neutral.
      What is 4FR’s MACD?
      4FR’s MACD is >-0.01, which suggests 4FR is a Sell.
        What is 4FR’s 5-day moving average?
        4FR’s 5-day moving average is 0.48, which suggests 4FR is a Buy.
          What is 4FR’s 20-day moving average?
          4FR 20-day moving average is 0.48, which suggests 4FR is a Sell.
            What is 4FR’s 50-day moving average?
            4FR’s 50-day moving average is 0.49, which suggests 4FR is a Sell.
              What is 4FR’s 200-day moving average?
              4FR’s 200-day moving average is 1.12, which suggests 4FR is a Sell.
                What is 4FR’s Williams % R (14)?
                4FR’s Williams % R (14) is -60.00, which suggests 4FR is a Buy.
                  What is 4FR’s CCI (14)?
                  4FR’s CCI (14) is -18.87, which suggests 4FR is a Neutral.
                    What is the share price of Faron Pharmaceuticals Oy?